General Information of Drug Inactive Ingredient (DIG) (ID: E00164)

DIG Name
Ethylene glycol ethyl ether
Synonyms
2-Ethoxyethanol; Cellosolve; 110-80-5; Oxitol; ETHYLENE GLYCOL MONOETHYL ETHER; Ethanol, 2-ethoxy-; Ethyl cellosolve; Ethyl glycol; Ethylene glycol ethyl ether; Emkanol; Hydroxy ether; Dowanol EE; Cellosolve solvent; 2-Ethoxyethyl alcohol; Plastiazan 60; Poly-Solv EE; Solvid; Ethylethylene glycol; EGEE; Jeffersol EE; Glycol monoethyl ether; beta-Ethoxyethanol; Bikanol E 1; Solvulose; Etoksyetylowy alkohol; 2-Ethoxyethan-1-Ol; Ektasolve EE; Dowanol 8; Celosolv; Ethyl ethylene glycol; Glycol ether EE; Glycol ethyl ether; NCI-C54853; .beta.-Ethoxyethanol; HSDB 54; Ethyl icinol; Ether monoethylique de l'ethylene-glycol; EE solvent; HOCH2CH2OC2H5; 2-ethoxy-ethanol; Athylenglykol-monoathylather; UNII-IDK7C2HS09; 2-Ethoxy ethanol; NSC 8837; Ethylene glycol monoethyl ether (EGMEE); Eter monoetilico del etilenglicol; Ethyl-2-hydroxyethyl ether; IDK7C2HS09; DTXSID7024087; CHEBI:46788; MFCD00002869; DSSTox_CID_4087; Celosolv [Czech]; DSSTox_RID_77284; DSSTox_GSID_24087; ETX; 2-Ethoxyethanol, for analysis; Ethoxyethanol, 2-; 2-Ethoxyethanol, 99%, extra pure; 2EE; CAS-110-80-5; Etoksyetylowy alkohol [Polish]; CCRIS 2294; EINECS 203-804-1; Athylenglykol-monoathylather [German]; UN1171; RCRA waste no. U359; 2-Ethoxyethanol (cellosolve); 2ethoxyethanol; ethylene glycol-monoethyl ether; 2-ethoxyetanol; AI3-01236; Eter monoetilico del etilenglicol [Spanish]; 2-Ehoxyethanol; 2-ethyoxyethanol; Cellosolve(R); Bikanol E1; ethoxyethyl alcohol; Ether monoethylique de l'ethylene-glycol [French]; 1-ethoxy-2-ethanol; EtOCH2CH2OH; CCOCC[O]; ethyl 2-hydroxyethyl ether; EC 203-804-1; ethyleneglycol monoethylether; ethylene glycol monoethylether; ethyleneglycol monoethyl ether; WLN: Q2O2; BIDD:ER0296; ACMC-20997c; CHEMBL119596; ethylene glycol mono ethyl ether; 2-Ethoxyethanol, ~99% (GC); 2-Ethoxyethanol, LR, >=99%; dimethylene glycol monoethyl ether; NSC8837; Ethylene glycol monoethyl ether [UN1171] [Flammable liquid]; NSC-8837; ZINC1648262; 2-Ethoxyethanol, analytical standard; Tox21_201697; Tox21_300031; ANW-16198; STL282734; AKOS000119042; DB02249; MCULE-4311513289; 2-Ethoxyethanol, for synthesis, 99.0%; 2-Ethoxyethanol, ReagentPlus(R), 99%; NCGC00091522-01; NCGC00091522-02; NCGC00091522-03; NCGC00254064-01; NCGC00259246-01; BP-31042; E0047; FT-0626330; Ethylene Glycol Monoethyl Ether Reagent Grade; 2-Ethoxyethanol, SAJ first grade, >=97.0%; C14687; 2-Ethoxyethanol, SAJ special grade, >=99.0%; 73915-EP2269986A1; 73915-EP2272849A1; 73915-EP2275469A1; 73915-EP2287940A1; 73915-EP2289965A1; 73915-EP2298828A1; 73915-EP2301983A1; 73915-EP2302003A1; 73915-EP2308926A1; 73915-EP2309564A1; 73915-EP2371809A1; 73915-EP2380568A1; 73915-EP2380873A1; 74375-EP2270895A2; 74375-EP2278637A1; 74375-EP2281821A1; 74375-EP2298828A1; 74375-EP2299785A1; 74375-EP2305667A2; 74375-EP2305825A1; 74375-EP2306788A1; 74375-EP2306789A1; 74375-EP2308857A1; 74375-EP2380568A1; 2-Ethoxyethanol, spectrophotometric grade, >=99%; Q209381; J-509307; F1908-0123; Z940713552; Ethylene glycol monoethyl ether [UN1171] [Flammable liquid]; 2-Ethoxyethanol, Pharmaceutical Secondary Standard; Certified Reference Material
DIG Function
Solubilizing agent; Solvent
Formula
C4H10O2
Canonical SMILES
CCOCCO
InChI
1S/C4H10O2/c1-2-6-4-3-5/h5H,2-4H2,1H3
InChIKey
ZNQVEEAIQZEUHB-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 90.12 Topological Polar Surface Area 29.5
XlogP -0.3 Complexity 21.5
Heavy Atom Count 6 Rotatable Bond Count 3
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 2

Full List of Drug(s) Co-administrated with This DIG

4 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Chlordiazepoxide DMTN5XI Alcohol withdrawal [] Chlordiazepoxide 10 mg capsule F03980
Ergocalciferol DMHO0AR Hypoparathyroidism [5A50] Ergocalciferol 50000 unt capsule F07343
Piroxicam DMTK234 Osteoarthritis [FA00-FA05] Piroxicam 10 mg capsule F17329
Tetracycline DMZA017 Acne vulgaris [ED80] Tetracycline 250 mg capsule F21016
------------------